|
|
|
|
|
|
|
Endo International plc (ENDP)
|
|
12.73 -0.18 (-1.39%)
|
11-15 16:00
|
|
Open:
|
12.83
|
Pre. Close:
|
12.91
|
|
High:
|
12.94
|
Low:
|
12.28
|
|
Volume:
|
4,199,444
|
Market Cap:
|
2856M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
12.956 - 13.037
|
13.037 - 13.094
|
|
Low:
|
12.093 - 12.191
|
12.191 - 12.261
|
|
Close:
|
12.597 - 12.745
|
12.745 - 12.85
|
|
|
|
Technical analysis (as of: 2018-11-15 4:30:27 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 18.83  One year: 21.61
|
|
Support:
|
Support1: 12.28 Support2: 10.22
|
|
Resistance:
|
Resistance1:
16.12 Resistance2: 18.50
|
|
Pivot:
|
15.31
|
|
Moving Averages:
|
MA(5): 13.17 MA(20): 15.82
MA(100): 14.82 MA(250): 10.10
|
|
MACD:
|
MACD(12,26):
-1.02 Signal(12,26,9): -0.57
|
|
%K %D:
|
%K(14,3): 11.30 %D(3): 13.14
|
|
RSI:
|
RSI(14): 28.69
|
|
52-Week:
|
High: 18.5
Low: 5.27 Change(%): 68.8
|
|
Average Vol(K):
|
3-Month: 431681
10-Days 596817
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ENDP has closed above bottom band by 13.8%. Bollinger Bands are 155.2% wider than normal. The large width of the bands suggest high volatility as compared to ENDP's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-11-13T09:43:56-05:00
Express Scripts launches new formulary aimed at reducing drug costs
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
